ArticleAmerican journal of clinical and experimental urology2025

Next-generation sequencing identifies the presence of protein phosphatase 1D, PPM1D, as a potential biomarker of resistance to PARP inhibition in metastatic castration-resistant prostate cancer.

Jordan E Vellky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.